Skip to main content
SpringerLink
Log in

SSRI exposure during pregnancy increases risk of speech disorders

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brown AS, et al. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. JAMA Psychiatry : 12 Oct 2016. Available from: URL: http://doi.org/10.1001/jamapsychiatry.2016.2594.

  2. Cohen LS, et al. Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks. JAMA Psychiatry : 12 Oct 2016. Available from: URL: http://doi.org/10.1001/jamapsychiatry.2016.2705.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

SSRI exposure during pregnancy increases risk of speech disorders. Reactions Weekly 1624, 11 (2016). https://doi.org/10.1007/s40278-016-22217-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-22217-x

Search

Navigation